Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 4/20 | 0.44 |
| ▸ | DPP8 | Q6V1X1 | 3/20 | 0.44 |
| ▸ | DPP9 | Q86TI2 | 3/20 | 0.44 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.44 |
| ▸ | FAP | Q12884 | 1/20 | 0.44 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | ECE1 | P42892 | 2/20 | 0.37 |
| ▸ | METAP1 | P53582 | 1/20 | 0.36 |
| ▸ | MALT1 | Q9UDY8 | 1/20 | 0.35 |
| ▸ | TERT | O14746 | 1/20 | 0.33 |
| ▸ | ARG1 | P05089 | 2/20 | 0.33 |
| ▸ | ARG2 | P78540 | 1/20 | 0.33 |
| ▸ | MME | P08473 | 1/20 | 0.32 |
| ▸ | ACE | P12821 | 1/20 | 0.32 |
| ▸ | CPA1 | P15085 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26291258 | 1.00 | DPP4 (0.44) | DPP4DPP8DPP9DPP7FAP | |
| SCHEMBL7199464 | 0.92 | DPP4 (0.43) | DPP4DPP8DPP9DPP7FAP | |
| SCHEMBL7199462 | 0.92 | DPP4 (0.43) | DPP4DPP8DPP9DPP7FAP | |
| Glycine SCHEMBL7544714 | 0.91 | ALDH1A1 (0.40) | DPP4DPP8DPP9DPP7FAP | |
| SCHEMBL30869183 | 0.85 | METAP1 (0.38) | DPP4DPP8DPP9ALDH1A1LMNA | |
| SCHEMBL24483749 | 0.83 | DPP4 (0.44) | DPP4DPP8DPP9DPP7FAP | |
| Val-Gly SCHEMBL2782029 | 0.83 | ALDH1A1 (0.57) | DPP4DPP8DPP9DPP7FAP | |
| SCHEMBL21444788 | 0.83 | DPP4 (0.44) | DPP4DPP8DPP9DPP7FAP | |
| Val-Gly SCHEMBL2782025 | 0.83 | ALDH1A1 (0.57) | DPP4DPP8DPP9DPP7FAP | |
| SCHEMBL27765116 | 0.83 | DPP4 (0.44) | DPP4DPP8DPP9DPP7FAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250129126-A1 | LONG-LASTING HEPATITIS VIRUS ENTRY INHIBITOR | Chengdu AODA Biotechnology Co., Ltd (CN) | 2025-04-24 | — | — | US | disclosed |
| WO-2023178299-A1 | PRODRUGS OF GANAXOLONE | MARINUS PHARMACEUTICALS, INC. (US) | 2023-09-21 | — | — | WO | disclosed |
| US-20220409734-A1 | ANTIBODY DRUG CONJUGATES | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2022-12-29 | — | — | US | disclosed |
| WO-2020219287-A1 | CAMPTOTHECIN DERIVATIVES | IMMUNOGEN, INC. (US) | 2020-10-29 | — | — | WO | disclosed |
| CN-108721599-A | Therapy with HTCP Inhibitors | MYR有限公司 | 2018-11-02 | — | — | CN | disclosed |
| EP-2780039-B1 | CYTOTOXIC PEPTIDES AND ANTIBODY DRUG CONJUGATES THEREOF | PFIZER (US) | 2017-11-29 | — | — | EP | disclosed |
| CN-107106686-A | Combination therapy for HBV and HDV infection | MYR有限公司 | 2017-08-29 | — | — | CN | disclosed |
| WO-2015120065-A1 | GAMMA-SECRETASE INHIBITION REDUCE APOC3 LEVELS AND PLASMA TRIGLYCERIDES | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2015-08-13 | — | — | WO | disclosed |
| WO-2014095773-A1 | PEPTIDES AS OXYTOCIN AGONISTS | F. HOFFMANN-LA ROCHE AG (CH) | 2014-06-26 | — | — | WO | disclosed |
| WO-1997040078-A1 | THERMOREVERSIBLE HYDROGELS COMPRISING NON-CROSSLINKED COPOLYMERS AND THEIR USE IN ELECTROPHORESIS | SOANE BIOSCIENCES (US) | 1997-10-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220409734-A1 | ANTIBODY DRUG CONJUGATES | STING1, CGAS, TBK1 | DPP4 2726/4885DPP8 2597/4885DPP9 1713/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.